Drugs / cTIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01561768 | Mar 2012 → Jan 2013 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cTIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01561768 ↗ |
| Modality | Vaccine | “commercially available trivalent influenza vaccine (TIV)” NCT01561768 ↗ |
| Route | Intramuscular | “intramuscular injection, deltoid” NCT01561768 ↗ |